Navigation Links
Aridol in Medical News

Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)

...n important underlying component of asthma." aridol will be a standardized test kit containing proprie...sing a proprietary hand-held inhaler. The goal of aridol is to provide physicians and health care professio...d Stephen Beckman, President, Pharmaxis, Inc. aridol is approved for sale in Australia, major European ...

Pharmaxis to Expand Manufacturing Capacity

...iratory and immune disorders. Its development pipeline of products include: aridol for the management of asthma, Bronchitol for cystic fibrosis, bronchiectasi...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...
Aridol in Medical Technology

Pharmaxis Reports Phase II Results for Aridol in COPD

SYDNEY, Australia, March 14, 2007 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced the results from its Phase II trial for Aridol in subjects with Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease affecting over 30 million people worldwide. The ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

...iratory and immune disorders. Its development pipeline of products includes aridol for the diagnosis of asthma, Bronchitol for cystic fibrosis, bronchiectasis...initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media re...

Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces New Drug Application Submission for Aridol(TM)

...ternational randomized pivotal Phase 3 trials with aridol involving over 1,000 subjects. The NDA applic...bronchial challenge test available in the U.S. and aridol is the first test of this kind that comes complete...s a substantial impact on the health of a nation. aridol was developed to assist with improving existing ma...

ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Bronchitol Cystic Fibrosis Dose Trial Results Positive

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...
Aridol in Biological Technology

Pharmaxis Aridol Approved for Sale in Switzerland

SYDNEY, Australia, Oct. 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that it had received approval to market Aridol from the Swiss therapeutic regulatory agency Swissmedic. Aridol is indicated for measuring airway hyperresponsi...

Pharmaxis' Aridol Authorised for Sale in Germany

SYDNEY, Australia, May 18 /Xinhua-PRnewswire-Firstcall/ -- Specialist Pharmaceutical Company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) today announced that it has received national approval to market Aridol in Germany. Aridol is indicated for measuring airway hyperresponsiveness and has been ap...

Pharmaxis' Aridol Gains First Asian Approval

SYDNEY, Jan. 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the Korean regulatory agency has granted marketing approval for its asthma management product, Aridol. "This is the first Asian approval of Aridol," said Pharmaxis Chief Executive Officer Dr A...

Pharmaxis Appoints Portuguese Distributor for Aridol

SYDNEY, Australia, Dec. 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of Pulmocor SA to market and distribute its asthma diagnostic tool, Aridol in Portugal. "Portugal was one of the 13 European countries included in the successful mut...

Pharmaxis Closes Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, an...

U.S. FDA Accepts Aridol(TM) New Drug Application for Review

...ber 2009. Pharmaxis is seeking approval for aridol for "the assessment of bronchial hyperresponsivene...ual economic cost of $19.7 billion. When approved, aridol will be the first dry powder bronchial challenge t...rking with the FDA to complete the review." aridol is approved for sale in most major European countr...

New Pharmaxis Board Appointment

... statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and...

Pharmaxis Appoints French Distributor for Aridol(TM)

...raxis on developing the French market for Aridol. aridol is a precisely engineered test that we believe will be an improvement on current practice. aridol improves the identification of bronchial hyperresp...ian that has previously not been available. aridol is approved for sale in most major European countr...
Other Tags
(Date:3/3/2015)... (PRWEB) March 03, 2015 Aurora Fit ... celebration and charity drive to observe the opening of the ... charity organization Ashleigh’s Hope. The event will be held on ... S #7, Aurora, ON. The opening will feature free boot ... Fit Body Boot Camp is the world’s most popular and ...
(Date:3/2/2015)... Formetco today announced the official launch ... FTX uses state-of-the-art technology to deliver an outdoor advertising ... satisfaction. An item of particular value, and previously ... year LED Brightness Warranty. , Why the FTX was ... billboard among any other billboard product in the world. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Dr. David ... injury, is partnering with Doctors on Liens ... patients. It’s rare for personal injury victims to ... and especially on a lien basis. However, San ... outstanding team of chiropractors, M.D., pain management physician, massage, ...
(Date:3/2/2015)... New York, NY (PRWEB) March 02, 2015 ... a long history of catalyzing private sector activities ... that it has recently elected four new members ... , GBCHealth welcomes Dr. Paul Farmer, Chief Strategist ... University Professor at Harvard University; Dr. Huma Abbasi, ...
(Date:3/2/2015)... 02, 2015 “ Wants and Needs ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this app helps people evaluate priorities. , Whether a ... Wants and Needs app. The app allows people to ...
Breaking Medicine News(10 mins):Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 2Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 3Health News:Formetco Launches Innovative LED Billboard System 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
Other Contents